Cover Image

Guidance for industry : providing regulatory submissions to CBER in electronic format, investigational new drug applications (INDs).

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2002]
Subjects:	Electronic filing systems > United States. Drugs > United States > Testing.
Online Access:	https://purl.fdlp.gov/GPO/LPS113079

Similar Items

Guidance for industry : providing regulatory submissions in electronic format, postmarketing indivudal case safety reports.
Published: (2008)

Guidance for industry : providing regulatory submissions in electronic format, receipt date.
Published: (2007)

Guidance for industry : providing regulatory submissions in electronic format, general considerations.
Published: (1999)

Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Published: (2009)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : providing regulatory submissions in electronic format, general considerations.
Published: (2003)

Guidance for industry : providing regulatory submissions to the Center for Biologics Evaluation and Research (CBER) in electronic format, lot release protocols.
Published: (2007)

Guidance for industry : providing regulatory submissions in electronic format, prescription drug advertising and promotional labeling.
Published: (2001)

Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Published: (2008)

Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
Published: (1995)

Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
Published: (1995)

Guidance for industry : submitting type V drug master files to the Center for Biologics Evaluation and Research.
Published: (2001)

Guidance for industry : nonclinical safety evaluation of drug or biologic combinations.
Published: (2006)

Guidance for industry : providing regulatory submissions in electronic format, content of labeling.
Published: (2005)

Guidance for industry : Q1B photostability testing of new drug substances and products.
Published: (1996)

Guidance for industry : CGMP for phase 1 investigational drugs.
Published: (2008)

Guidance for industry : investigating out-of-specification test results (OOS) for pharmaceutical production.
Published: (2006)

Guidance for industry : nonclinical safety evaluation of pediatric drug products.
Published: (2006)

Guidance for industry : stability testing, photostability testing of new veterinary drug substances and medicinal products.
Published: (1999)

Guidance for industry : photosafety testing.
Published: (2003)

Guidance for industry : statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.
Published: (2001)

Guidance for industry and review staff : nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate route.
Published: (2008)

Guidance for industry : Q1A(R2) stability testing of new drug substances and products.
Published: (2003)

Guidance for industry : Q1D bracketing and matrixing designs for stability testing of new drug substances and products.
Published: (2003)

Guidance for industry : analytical procedures and methods validation, chemistry, manufacturing, and controls documentation.
Published: (2000)

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.
Published: (2009)

Guidance for industry : dosage delivery devices for OTC liquid drug products.
Published: (2009)

Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers.
Published: (2008)

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.
Published: (2007)

Guidance for industry : S1B testing for carcinogenicity of pharmaceuticals.
Published: (1997)

Guidance for industry : handling and retention of BA and BE testing samples.
Published: (2004)

Marine employers drug testing guidance : (what marine employers need to know about drug testing) /
Published: (2005)

Guidance for industry : single dose acute toxicity testing for pharmaceuticals.
Published: (1996)

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.
Published: (2010)

Guidance for industry : preparation of IDEs and INDs for products intended to repair or replace knee cartilage.
Published: (2007)

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.
Published: (2008)

Guidance for industry : PAC-ATLS : postapproval changes, analytical testing laboratory sites.
Published: (1998)

Guidance for industry : submission of summary bioequivalence data for ANDAs.
Published: (2009)

Guidance for industry : accelerated approval products, submission of promotional materials.
Published: (1999)